Congenital Cytomegalovirus: Prevalence in Buenos Aires City (cCMV Prevalence)
Launched by HOSPITAL DE NIÑOS R. GUTIERREZ DE BUENOS AIRES · Nov 18, 2022
Trial Information
Current as of June 04, 2025
Unknown status
Keywords
ClinConnect Summary
Cytomegalovirus (CMV) is a frequent cause of congenital infection and a leading nongenetic cause of sensorineural hearing loss. In most infants with congenital CMV infection, clinical abnormalities do not manifest at birth; rather, the infection is asymptomatic. However, sensorineural hearing loss eventually develops in approximately 10 to 15% of CMV positive children.
The prevalence of congenital cytomegalovirus has been reported as 0·2% to 2·0% (average of 0·64%). There is not any publication of the prevalence of cCMV in Buenos Aires City. We aim the study to find the prevalence in this ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Newborns between 1 and 21 days
- • informed consent
- Exclusion Criteria:
- • Lethal malformation
About Hospital De Niños R. Gutierrez De Buenos Aires
Hospital de Niños R. Gutiérrez de Buenos Aires is a leading pediatric institution dedicated to advancing child health through comprehensive clinical care, innovative research, and medical education. As a prominent clinical trial sponsor, the hospital is committed to conducting rigorous and ethical research aimed at improving treatment outcomes for pediatric patients. With a focus on collaboration among multidisciplinary teams and adherence to the highest standards of safety and efficacy, Hospital de Niños R. Gutiérrez plays a vital role in the development of new therapies and interventions, contributing to the global body of knowledge in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ciudad Autonoma De Buenos Aires, Buenos Aires, Argentina
Ciudad Autonoma De Buenos Aires, Buenos Aires, Argentina
Ciudad Autonoma De Buenos Aires, Buenos Aires, Argentina
Patients applied
Trial Officials
Daniela Satragno, MD
Principal Investigator
Hospital de Niños Ricardo Gutierrez
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials